Design and characterization of controlled release gastro-retentive floating tablet of an atypical psychotropic agent

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue SUPPL., 2012, Pages 88-89

  Ukawala, Ravikumar ^a   Singhvi, Gautam ^a   Jain, Suresh ^b   Shukla, Vipin ^a   Yadav, Nilesh ^a   Sharma, Sohiny ^a  

^a B I T S Pilani ^*  (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Floating drug delivery; gastro retentive; Quetiapine Fumarate

Indexed keywords

BICARBONATE; CARBOMER; CARBOXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; QUETIAPINE;

CONFERENCE PAPER; DRUG DESIGN; DRUG RELEASE; EXCIPIENT COMPATIBILITY; IN VITRO STUDY; MATRIX TABLET; PH; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET FORMULATION; TABLET MANUFACTURE;

EID: 84860454315     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.94151     Document Type: Conference Paper

References (6)

1. Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability study. Clin Ther. 2001;23:1839-54. (Pubitemid 33121972)
2. Figueroa C, Brecher M, Hamer-Maansson JE, Winter H. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsycho-pharmacol Biol Psychiatry. 2009;33:199-204.
3. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm Res. 1997;14:815-19. (Pubitemid 27281680)
4. Singh BN, Kim KH. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235-59.
5. Groning R, Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev Ind Pharm. 1984;10:527-39. (Pubitemid 14122735)
6. Baumgartner S, Kristel J, Vreer F, Vodopivec P, Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm. 2000;195:125-35. (Pubitemid 30089497)